CSIMarket
 
Endra Life Sciences Inc   (NASDAQ: NDRA)
Other Ticker:  
 
 
Price: $4.1796 $-0.12 -2.800%
Day's High: $4.515 Week Perf: 3.71 %
Day's Low: $ 4.10 30 Day Perf: -10.12 %
Volume (M): 5 52 Wk High: $ 38.15
Volume (M$): $ 22 52 Wk Avg: $6.76
Open: $4.42 52 Wk Low: $1.05



 Market Capitalization (Millions $) 0
 Shares Outstanding (Millions) 0
 Employees 19
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -9
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 0

Endra Life Sciences Inc
Endra Life Sciences Inc is a medical technology company that specializes in the development and commercialization of innovative imaging solutions. The company focuses on combining ultrasound technology with advanced algorithms to provide non-invasive, accurate, and cost-effective medical imaging solutions.

Endra Life Sciences' flagship product is the Thermo Acoustic Enhanced UltraSound (TAEUS) system, which uses a combination of ultrasound and thermal mapping to visualize tissue function and assess various diseases. This technology has the potential to improve diagnosis and treatment monitoring for conditions such as liver disease, cardiovascular disease, and cancer.

The company aims to provide a non-invasive alternative to invasive and expensive procedures, reducing healthcare costs and improving patient outcomes. Endra Life Sciences is committed to advancing medical imaging technology and revolutionizing the way diseases are diagnosed and managed.


   Company Address: 3600 Green Court Ann Arbor 48105 MI
   Company Phone Number: 335-0468   Stock Exchange / Ticker: NASDAQ NDRA


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
AVGR   -1.25%    
DRIO   -9.66%    
DXCM   -3.44%    
GCTK   -41.38%    
MDT   -1.49%    
UBI   -1.49%    
• View Complete Report
   



Business Update

Endra Life Sciences Bounces Back Regaining Compliance Amidst Market Struggles

Published Mon, Nov 25 2024 12:47 AM UTC

In a notable turn of events for Endra Life Sciences Inc., the Ann Arbor-based innovator of Thermo Acoustic Enhanced UltraSound (TAEUS), the company has successfully reclaimed compliance with the Nasdaq s minimum bid price requirement. On November 21, 2024, Endra announced that it received a notification from the Nasdaq Listing Qualifications Department confirming adherence t...

Business Update

Endra Life Sciences Reclaims Nasdaq Compliance Amidst Competitive Landscape Challenges

Published Sat, Nov 23 2024 2:48 AM UTC

In a notable development for the financial health and operational integrity of Endra Life Sciences Inc. (NASDAQ: NDRA), the company recently announced that it has successfully regained compliance with The Nasdaq Stock Market s minimum bid price requirement. This milestone is significant, as it reinforces Endra s commitment to meeting the stringent regulatory standards and ma...

Business Update

ENDRA Life Sciences Achieves Compliance with Nasdaq Minimum Bid Price Standards

Published Fri, Nov 22 2024 1:47 PM UTC

In a notable milestone for shareholders and stakeholders, ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneering entity in the realm of Thermo Acoustic Enhanced UltraSound (TAEUS), has successfully regained compliance with the minimum bid price requirement mandated by The Nasdaq Stock Market LLC. The announcement, made on November 21, 2024, reveals that ENDRA received officia...

Business Update

ENDRA Life Sciences Innovates with New Patent Amidst Financial Struggles,

Published Wed, Nov 6 2024 1:36 PM UTC

In an era where technological advancement in medical devices is crucial, ENDRA Life Sciences Inc. (NASDAQ: NDRA) has m...

Business Update

ENDRA Life Sciences Reports Positive Developments Amid Leadership Changes and Improved Financial Metrics

Published Fri, Aug 23 2024 6:40 AM UTC

In a recent financial update, ENDRA Life Sciences Inc. (NASDAQ: NDRA) showcased significant strides in its operations and financial health for the second quarter of 2024. The company, based in Ann Arbor, Michigan, is recognized for its innovative Thermo Acoustic Enhanced Ultrasound (TAEUS) technology, which aims to enhance diagnostic imaging.In a Form 10-Q submitted on Augus...










Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com